AMLODIPINE BESYLATE
NDC 51655-869, AMLODIPINE BESYLATE, tablet, from Northwind Health Company, LLC.
- Product NDC
- 51655-869
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077073
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51655-869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMLODIPINE BESYLATE10 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51655-869-26 | 51655086926 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-869-26) |
| 51655-869-52 | 51655086952 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-869-52) |
| 51655-869-83 | 51655086983 | 180 TABLET in 1 BOTTLE, PLASTIC (51655-869-83) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/03fe9ad2-3a1a-78db-e063-6294a90a2ed3
Use it
Look up 51655-869 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51655-869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51655-869. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.